Oxford Global NextGen Omics UK 2024
Explore NextGen Omics 2024: Unlocking Future Insights in Multi-Omics Research. Join 700+ leaders, experts and researchers at Oxford Global’s flagship NextGen Omics 2024, featuring the 16th Annual NGS & Clinical Diagnostics Congress, 12th Annual Single Cell & Spatial Analysis Congress and 6th Annual Digital PCR & Liquid Biopsies Congress and CRISPR-Based Medicine Congress.
Meet the NanoString, now Bruker Spatial Biology team at booth #49.
Sponsored Workshop | Wednesday 25th October | 14:00 – 17:00 | CONFERENCE ROOM 1
Unlock the potential of your samples with the GeoMx® Digital Spatial Profiler and CosMx™ Spatial Molecular Imager
- Obtain new ideas, approaches and lessons learned relating to spatial transcriptomics to better understand how to apply spatial technologies in your research. Achieve multicellular analysis with GeoMx® Digital Spatial Profiler, or zoom in to view single cells with the CosMx™ Spatial Molecular Imager (SMI).
- Hear from current users about insights they have gained by unravelling biological complexity using spatial technologies.
- Analyzing Spatial Data: Learn how to evaluate spatial performance of single cell spatial imaging technologies to deliver more biological information with high quality data. Gain spatial biology insights anytime, anywhere using AtoMx™ Spatial Informatics Platform (SIP), a cloud-based solution that provides advanced data analytics and global collaboration capabilities.
AGENDA
- Introduction to Bruker Spatial Biology GeoMx DSP and CosMx SMI | Christoph Koenig, NanoString a Bruker Company
- Joshua Harvey, Postdoctoral Research Associate, University of Exeter, “Spatial transcriptomics to resolve neuronal dysfunction in Alzheimer’s disease”
- Scott Hoffmann, Associate Director, Astra Zeneca, “Integration of global proteomic and spatial transcriptomic data for novel insights in pre-clinical drug development”
- Panel Discussion “The future of Spatial Multiomics” – All
In-event presentation | Thursday 24th October | 11:40 – 12:05 | CONFERENCE ROOM 2
Identifying Early Signs Of Cancer Initiation In Histologically Normal Breast Tissue To Improve Risk Assessment Of Germline BRCA 1/2 Mutation Carriers
An AI-driven spatial transcriptomic study on gBRCA1/2 mutation carriers aiming to uncover molecular insights into tissue heterogeneities and accelerated aging, using H&E-stained whole slide images to develop personalised breast cancer risk assessments.
- See how the CosMx™ Spatial Molecular Imager is applied to personalised breast cancer risk assessments.